Get the Stockscreener App
4.64
0.00%
0.00
Cargo Therapeutics Inc stock is traded at $4.64, with a volume of 461.23K.
It is up +0.00% in the last 24 hours and up +12.90% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
See More
Previous Close:
$4.64
Open:
$4.61
24h Volume:
461.23K
Relative Volume:
0.44
Market Cap:
$205.39M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-1.294
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
+14.00%
1M Performance:
+12.90%
6M Performance:
-78.62%
1Y Performance:
-76.21%
1-Day Range:
$4.54
$4.72
1-Week Range:
$4.065
$4.72
52-Week Range:
$3.00
$25.45
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
4.64 | 205.39M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-30-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-30-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Jan-30-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-30-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-30-25 | Downgrade | Truist | Buy → Hold |
| Jan-30-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
Vanguard Group Inc. Purchases 22,286 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
American Century Companies Inc. Invests $474,000 in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Rating of “Reduce” from Analysts - Defense World
Cargo Therapeutics executive Anup Radhakrishnan sells $6,522 in stock By Investing.com - Investing.com South Africa
Trial misses sink cancer stocks in Q1: Mersana, Cargo, Mural fall - BioWorld MedTech
Cargo Therapeutics executive Anup Radhakrishnan sells $6,522 in stock - Investing.com
Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Swiss National Bank Boosts Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Brokers Offer Predictions for CRGX FY2025 Earnings - Defense World
Is CARGO Therapeutics (NASDAQ:CRGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Biotech company based in Peninsula laying off 90% of staff - MSN
Finance Watch: Cargo Restructuring Not The News The IPO Market Needs - insights.citeline.com
California-Based Biotech Therapeutics Firm Lays Off 90% of Workforce - NewsBreak: Local News & Alerts
Fierce Biotech Layoff Tracker 2025: Cargo lays off 90% of staff; Empress halves workforce - Fierce Biotech
Bay Area biotech company laying off 90% of staff as CEO leaves - San Francisco Chronicle
Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff - SFGATE
CARGO THERAPEUTICS Earnings Preview: Recent $CRGX Insider Trading, Hedge Fund Activity, and More - Nasdaq
90% Workforce Reduction Sent This Small Cap Soaring - The Globe and Mail
CARGO Stock Surges 19% Pre-Market After Suspending Development, Cutting 90% of Workforce - GuruFocus.com
Cargo Therapeutics scraps R&D pipeline, axes bulk of workforce as it looks for an exit - Endpoints News
Cargo shelves cell therapy research, lays off more staff - BioPharma Dive
Cargo Lays Off 90% of Staff and Stops Development Work - BioSpace
CARGO Therapeutics (CRGX) Stock Climbs In Pre-Hour Market - Stocks Telegraph
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga
After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more - Investing.com
Once-high-flying Cargo Therapeutics looks to ditch remaining work as CEO exitsSan Francisco Business Times - The Business Journals
Cargo Therapeutics provides corporate update -March 18, 2025 at 05:43 pm EDT - Marketscreener.com
CARGO Therapeutics halts development, cuts 90% of staff By Investing.com - Investing.com Australia
CARGO Therapeutics rises after hours on workforce reduction - MSN
CARGO Therapeutics halts development, cuts 90% of staff - Investing.com
CARGO Therapeutics Announces Major Workforce Reduction - TipRanks
Cargo suspends CRG-023 and allogeneic platform, reduces workforce by 90% - TipRanks
CARGO Therapeutics Suspends Development of CRG-023 and Allogeneic Platform, Appoints Interim CEO and Reduces Workforce by 90% - Nasdaq
CARGO Therapeutics Provides Corporate Update - The Bakersfield Californian
Major Shakeup: CARGO Therapeutics Ends All Programs Despite $368M Cash Position - StockTitan
William Blair Expects Weaker Earnings for CARGO Therapeutics - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
CARGO Therapeutics, Inc.: Hold Rating Amidst Developmental Stagnation and Future Prospects - TipRanks
CARGO Therapeutics (CRGX) to Release Quarterly Earnings on Thursday - Defense World
CARGO Therapeutics Inc. (CRGX) reports earnings - Quartz
Levi & Korsinsky Reminds Shareholders of an Investigation into CARGO Therapeutics, Inc. (CRGX) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Airline Stocks To Research – March 2nd - Defense World
Checkpoint Therapeutics: Pivoting From Approval To Gutsy Next Shot On Goal (NASDAQ:CKPT) - Seeking Alpha
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):